USP invites volunteers to test new drugs for HIV prevention – São Paulo



Analysis will assess whether the long-term injection is as effective as its & # 39; oral remedy currently used

Das Clínicas Hospital is in the USP Medical School which includes a network of more than 43 centers in the seven countries that host; test HIV prevention drug that prevents HIV. The drug of Cabotegravir, an interesting injection of the drug, is placed every two months, capable of maintaining appropriate levels of the drug in the blood.

According to Administration and Health, young people under the age of 30, "female women and armies can participate in the first study in Brazil."

The aim is to know if the injection of every eight weeks is safe and effective in preventing HIV as the oral remedy that is being carried out; currently used. It is a mixture of drugs that are currently in the drug; offered by the Integrated Health System in record form.

The international clinical test, funded by the AIDS Department of the National Health Institutes of the United States, is already proven worldwide.

"Today, there are 17 anti-clan types. Obstruction of diseases that are drawn to sex will continue to follow the same steps," arguing the infectious doctor Ricardo Vasconcelos, a co-ordinator of HC Project HPTN 083.

The campaign should go with the total of 4,500 volunteers over three and a half years.

In addition to the USP Hospital for Clinics, exams in São Paulo are also held at the DST / AIDS-SP Advocacy and Training Center. The Evandro Chagas Clinical Research Institute (IPEC) of the Oswaldo Cruz-FIOCRUZ Foundation in Rio de Janeiro, and the Nossa Senhora da Conceição Hospital in Porto Alegre, are part of the network in Brazil.

Those interested in participating in the São Paulo survey should contact us at (11) 94996-6134 and (11) 2661-2275, by email: agendamento. [email protected]


Source link